“…Probing the transcriptional responses provides clues as to what the compositionally altered plasma may activate in endothelial cells, but whether such changes are sufficient to impact homeostasis remains unclear. Based on recent findings of roles for multiligand receptors LOX-1 (Lund, Lucero et al 2011), TLR4 (Kampfrath, Maiseyeu et al 2011), and CD36 (Robertson, Colombo et al 2013, Rao, Zhong et al 2014), all of which could generate a portion of the inflammatory signaling responses observed in the plasma-treated endothelial cells (Silverstein and Febbraio 2009, Sikorski, Czerwoniec et al 2011, Pirillo, Norata et al 2013), ligands to such receptors are a likely intermediate that could be assessed in future research.…”